Brent Saunders, incoming Bausch + Lomb CEO (Richard Drew/AP Images)
February 15, 2023 07:44 AM ESTUpdated 08:24 AM
People
Pharma

Brent Saun­ders to lead Bausch + Lomb in re­turn to CEO slot

Amber Tong

John Carroll

Editor & Founder

Three years af­ter com­plet­ing Al­ler­gan’s $63 bil­lion sale to Ab­b­Vie and walk­ing away with a near­ly $39 mil­lion gold­en para­chute, Brent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

No­vo de­clares Phase 3 car­diac out­comes tri­al win for oral GLP-1

Star­board takes ac­tivist stake in J&J con­sumer spin­out Ken­vue

For­mer Karuna crew quick­ly as­sem­bles $225M for next neu­ro bet at Sea­port

Q3 biotech roundup: The 2024 turn­around sput­ters in­to a crit­i­cal Q4 fi­nale

As­traZeneca-backed CD­MO Nu­cle­us Ra­dio­Phar­ma to boost com­mer­cial ca­pac­i­ty

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times